Anti-colon cancer and antioxidant activities of bovine skim milk fermented by selected Lactobacillus helveticus strains

Journal of Dairy Science

Volumn 99, Issue 1, 2016, Pages 31-40

  Elfahri, K R ^a   Vasiljevic, T ^a   Yeager, T ^a   Donkor, O N ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

Anti colon cancer; Antioxidant; Fermentation; Lactobacillus helveticus

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; MILK PROTEIN;

ANIMAL; CHEMISTRY; COLONIC NEOPLASMS; FERMENTATION; GENETICS; HT 29 CELL LINE; HUMAN; LACTOBACILLUS HELVETICUS; METABOLISM; MILK; PROTEIN DEGRADATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; COLONIC NEOPLASMS; FERMENTATION; HT29 CELLS; HUMANS; LACTOBACILLUS HELVETICUS; MILK; MILK PROTEINS; PROTEOLYSIS;

EID: 84952720092     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2015-10160     Document Type: Article

References (48)

1. Ashar M., Chand R. Fermented milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects. Milchwissenschaft 2004, 59:363-366.
2. Benbrook C.M. Elevating Antioxidant Levels in Food Through Organic Farming and Food Processing 2005, The Organic Center, Foster, RI.
3. Chau I., Cunningham D. Adjuvant therapy in colon cancer: Current status and future directions. Cancer Treat. Rev. 2002, 28:223-236.
4. Church F., Swaisgood H., Porter D., Catignani G. Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins. J. Dairy Sci. 1983, 66:1219-1227.
5. Curigliano G., Mayer E., Burstein H., Winer E., Goldhirsch A. Cardiac toxicity from systemic cancer therapy: A comprehensive review. Prog. Cardiovasc. Dis. 2010, 53:94-104.
6. Donkor O., Henriksson A., Vasiljevic T., Shah N. Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 2007, 87:21-38.
7. Dryáková A., Pihlanto A., Marnila P., Čurda L., Korhonen H. Antioxidant properties of whey protein hydrolysates as measured by three methods. Eur. Food Res. Technol. 2010, 230:865-874.
8. Elfahri K., Donkor O., Vasiljevic T. Potential of novel Lactobacillus helveticus strains and their cell wall bound proteases to release physiologically active peptides from milk proteins. Int. Dairy J. 2014, 38:37-46.
9. Eliassen L.T., Berge G., Leknessund A., Wikman M., Lindin I., Løkke C., Ponthan F., Johnsen J., Sveinbjørnsson B., Kogner P. The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo. Int. J. Cancer 2006, 119:493-500.
10. Freiburghaus C., Janicke B., Lindmark H., Oredsson M., Paulsson A. Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line. J. Dairy Sci. 2009, 92:2477-2484.
11. Ganjam L.S., Thornton W., Marshall R., Macdonald R. Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells. J. Dairy Sci. 1997, 80:2325-2329.
12. Gupta A., Mann B., Kumar R., Sangwan R.B. Antioxidant activity of Cheddar cheeses at different stages of ripening. Int. J. Dairy Technol. 2009, 62:339-347.
13. Hernández B., Miralles B., Amigo L., Ramos M., Recio I. Identification of antioxidant and ACE-inhibitory peptides in fermented milk. J. Sci. Food Agric. 2005, 85:1041-1048.
14. Hoskin D., Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 2008, 1778:357-375.
15. Huang Y.B., Wang X., Wang H., Liu Y., Chen Y. Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Mol. Cancer Ther. 2011, 10:416-426.
16. Itano O., Fan K., Yang K., Suzuki K., Quimby F., Dong Z., Jin B., Edelmann W., Lipkin M. Effect of caloric intake on western-style diet-induced intestinal tumors in a mouse model for hereditary colon cancer. Nutr. Cancer 2012, 64:401-408.
17. Jemal A., Bray F., Center M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
18. Johannesdottir S.A., Lash T., Jensen A., Farkas D., Olesen A. Mortality in cancer patients with a history of cutaneous squamous cell carcinoma-A nationwide population-based cohort study. BMC Cancer 2012, 12:126.
19. Kakde D., Jain D., Shrivastava V., Kakde R., Patil A. Cancer therapeutic-Opportunities, challenges and advances in drug delivery. J. Appl. Pharm. Sci. 2011, 2011:1-10.
20. Kannan A., Hettiarachchy N., Marshall M. Food proteins and peptide as bioactive agents. Bioactive Food Proteins and Peptides, Applications in Human Health 2012, 1-28. CRC Press, Boca Raton, FL.
21. Kilpi E., Kahala M., Steele J., Pihlanto A., Joutsjoki V. Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32. Int. Dairy J. 2007, 17:976-984.
22. Kim S.E., Kim H., Kim J., Kang Y., Woo H., Lee H. Anticancer activity of hydrophobic peptides from soy proteins. Biofactors 2000, 12:151-155.
23. Korhonen H., Pihlanto A. Bioactive peptides: Production and functionality. Int. Dairy J. 2006, 16:945-960.
24. Korhonen H.J. Bioactive Components in Bovine Milk 2009, Wiley-Blackwell, Ames, IA.
25. Kozu T., Iinuma G., Ohashi Y., Saito Y., Akasu T., Saito D., Alexander D.B., Iigo M., Kakizoe T., Tsuda H. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev. Res. (Phila.) 2009, 2:975-983.
26. Kudoh Y., Matsuda S., Igoshi K., Oki T. Antioxidative peptide from milk fermented with Lactobacillus delbrueckii ssp. bulgaricus IFO13953. Jpn. Food Sci. Technol. J. 2001, 48:44-50. http://dx.doi.org/10.3136/nskkk.48.44.
27. Kunji E.R., Mierau I., Hagting A., Poolman B., Konings W. The proteolytic systems of lactic acid bacteria. Antonie van Leeuwenhoek 1996, 70:187-221.
28. Li Z., Jiang A., Yue T., Wang J., Wang Y., Su J. Purification and identification of five novel antioxidant peptides from goat milk casein hydrolysates. J. Dairy Sci. 2013, 96:4242-4251.
29. MacDonald R.S., Thornton W., Marshall R. A cell culture model to identify biologically active peptides generated by bacterial hydrolysis of casein. J. Dairy Sci. 1994, 77:1167-1175.
30. Mader J.S., Smyth D., Marshall J., Hoskin D.W. Bovine lactoferricin inhibits basic fibroblast growth factor-and vascular endothelial growth factor 165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. Am. J. Pathol. 2006, 169:1753-1766.
31. Madhu A., Amrutha N., Prapulla S. Characterization and antioxidant property of probiotic and synbiotic yogurts. Probiotics Antimicrob. Proteins 2012, 4:90-97.
32. Meisel H., FitzGerald R. Biofunctional peptides from milk proteins: Mineral binding and cytomodulatory effects. Curr. Pharm. Des. 2003, 9:1289-1295.
33. Mogili S., Yousaf M., Nadaraja N., Woodlock T. Management of advanced colon cancer in a community hospital: Impact of age on clinical management and survival. J. Gastrointest. Cancer 2012, 43:426-430.
34. Nielsen M., Martinussen T., Flambard B., Sørensen K., Otte J. Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: Effect of bacterial strain, fermentation pH, and storage time. Int. Dairy J. 2009, 19:155-165.
35. Nishino T., Shibahara-Sone H., Kikuchi-Hayakawa H., Ishikawa F. Transit of radical scavenging activity of milk products prepared by Maillard reaction and Lactobacillus casei strain Shirota fermentation through the hamster intestine. J. Dairy Sci. 2000, 83:915-922.
36. O'Leary B.A., Olynyk J.K., Neville A.M., Platell C.F. Cost-effectiveness of colorectal cancer screening: Comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J. Gastroenterol. Hepatol. 2004, 19:38-47.
37. Osuntoki A., Korie I. Antioxidant activity of whey from milk fermented with Lactobacillus species isolated from Nigerian fermented foods. Food Technol. Biotechnol. 2010, 48:505.
38. Pérez-Tomás R. Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment. Curr. Med. Chem. 2006, 13:1859-1876.
39. Phelan M., Aherne A., FitzGerald R., O'Brien N. Casein-derived bioactive peptides: Biological effects, industrial uses, safety aspects and regulatory status. Int. Dairy J. 2009, 19:643-654.
40. Qian B., Xing M., Cui L., Deng Y., Xu Y., Huang M., Zhang S. Antioxidant, antihypertensive, and immunomodulatory activities of peptide fractions from fermented skim milk with Lactobacillus delbrueckii ssp. bulgaricus LB340. J. Dairy Res. 2011, 78:72-79.
41. Roufik S., Gauthier S., Turgeon S. In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin. Int. Dairy J. 2006, 16:294-302.
42. Roy M.K., Kuwabara Y., Hara K., Watanabe Y., Tamai Y. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells. J. Dairy Sci. 2002, 85:2065-2074.
43. Sah B.N., Vasiljevic T., McKechnie S., Donkor O. Effect of probiotics on antioxidant and antimutagenic activities of crude peptide extract from yogurt. Food Chem. 2014, 156:264-270.
44. Sah B.N.P., Vasiljevic T., McKechnie S., Donkor O.N. Identification of anticancer peptides from bovine milk proteins and their potential roles in management of cancer: A critical review. Compr. Rev. Food Sci. Food Saf. 2015, 14:123-138.
45. Tsuda H., Sekine K., Fujita K., Iigo M. Cancer prevention by bovine lactoferrin and underlying mechanisms: A review of experimental and clinical studies. Biochem. Cell Biol. 2002, 80:131-136.
46. Vermeirssen V., Deplancke B., Tappenden K., Camp J., Gaskins H., Verstraete W. Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer. J. Pept. Sci. 2002, 8:95-100.
47. Virtanen T., Pihlanto A., Akkanen S., Korhonen H. Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria. J. Appl. Microbiol. 2007, 102:106-115.
48. Walsh D.J., Bernard H., Murray B., MacDonald J., Pentzien A., Wright G., Wal J., Struthers A., Meisel H., FitzGerald R. In vitro generation and stability of the lactokinin β-lactoglobulin fragment (142-148). J. Dairy Sci. 2004, 87:3845-3857.